DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment


Oncology Homepage

Supplemental breast MR superior to ultrasound for screening breast cancer survivors But what about cost-effectiveness?

German researchers find sweet alternative to conventional MR contrast agents Imaging with glucose using 7T MR scanner

RaySearch inks OIS deal with the University of Wisconsin-Madison Planned launch in second half of 2017

Michigan cancer center is first to acquire MR linac radiation therapy system Henry Ford is installing the MRIdian Linac from ViewRay

Experts develop ultrasound scoring system guidelines for thyroid nodules May reduce unnecessary biopsies

PET/CT with Ga-68 finds prostate cancer sooner than conventional imaging Research from Australia presented at SNMMI

Researchers to undertake largest breast cancer clinical trial in Oklahoma Findings may have practice-changing implications

Precision-based medicine improves outcomes and drives down costs How oncologists are seeking ways to provide affordable and effective care

Siemens scores FDA approval for latest version of its syngo.via VB20 for MI software Equipped with a series of improved features

Mammogram screening and overdiagnosis: tumor size an issue? New NEJM report sparks opposing views in screening debate

Dr. Aaron Laviana

Lifting the veil on low-risk prostate cancer treatment costs

by Lauren Dubinsky , Senior Reporter
As the industry meanders from a fee-for-service model to accountable care organizations and bundled payments, understanding the true cost of services is a critical — and frequently baffling — challenge. By tracking the cost of different treatments for low-risk prostate cancer over 12 years, UCLA researchers have determined that the costs vary significantly from one treatment to the next.

The researchers arrived at this conclusion by using the time-driven activity based costing (TDABC) method of calculating total expenses. Unlike traditional costing methods, which are often arbitrary and lack transparency, the researchers believe the TDABC method yields greater insight into the true cost of care.

Story Continues Below Advertisement

Streamline Your Radiology Workflow with RamSoft's PowerServer RIS/PACS

The PowerServer RIS/PACS is a single database application, essential to reducing redundant work, limiting manual data entry, and increasing consistency throughout healthcare practices. Click to learn how it will help you improve patient care and more.

“By breaking down the costs of treatment to the individual process, we were able to see the exact cost of every step involved in treating localized, low-risk prostate cancer, allowing us to target areas of inefficiency and excess cost in the future,” Dr. Aaron Laviana, first author of the study, told HCB News. “This is also an important piece in the era of accountable care organizations, when health care providers and organizations are going to be held more accountable for all of their costs.”

The biggest surprise for Laviana was the relatively low cost of active surveillance, which involves repeat prostate-specific antigen (PSA) testing and prostate biopsies to track the occurrence of more aggressive disease in younger and healthier patients. But even though active surveillance costs about $7,298, 30 to 50 percent of patients choose definitive treatment instead.

The cost of intensity-modulated radiation therapy (IMRT) — $23,565 — is significantly more expensive than high-dose brachytherapy and stereotactic body radiation therapy, which cost $11,448 and $11,665 respectively. Low-dose rate brachytherapy is even less expensive at $8,978.

Robotic-assisted laparoscopic prostatectomy costs $16,946 because of the high price of the equipment and inpatient stays. Cryotherapy, which involves freezing the tumor, costs $11,215 because a single use of the equipment costs $6,292 compared to a single use of brachytherapy equipment, which is $1,869.

The next step for the researchers is to determine whether the differences in costs are connected to outcomes. Active surveillance is cheaper up front, but it has not been studied extensively, especially when considering that a significant number of patients choose another treatment.

“We are not advocating that treatment modalities be chosen solely on costs; rather, the collective picture needs to be analyzed when assessing the overall value (quality & costs) of each option,” said Laviana.

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2017, Inc.